nodes	percent_of_prediction	percent_of_DWPC	metapath
Zanamivir—NEU2—Sialic acid metabolism—NANP—malaria	0.0962	0.301	CbGpPWpGaD
Zanamivir—NEU2—Synthesis of substrates in N-glycan biosythesis—NANP—malaria	0.0668	0.209	CbGpPWpGaD
Zanamivir—NEU2—Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein—NANP—malaria	0.0546	0.171	CbGpPWpGaD
Zanamivir—NEU2—Asparagine N-linked glycosylation—NANP—malaria	0.0347	0.109	CbGpPWpGaD
Zanamivir—NEU2—Post-translational protein modification—NANP—malaria	0.0179	0.0562	CbGpPWpGaD
Zanamivir—Toxic epidermal necrolysis—Pyrimethamine—malaria	0.0123	0.0181	CcSEcCtD
Zanamivir—Stevens-Johnson syndrome—Pyrimethamine—malaria	0.0104	0.0153	CcSEcCtD
Zanamivir—Influenza-like symptoms—Pentoxifylline—malaria	0.00896	0.0132	CcSEcCtD
Zanamivir—Erythema multiforme—Pyrimethamine—malaria	0.00893	0.0131	CcSEcCtD
Zanamivir—NEU2—Metabolism of proteins—NANP—malaria	0.00852	0.0267	CbGpPWpGaD
Zanamivir—Delirium—Quinidine barbiturate—malaria	0.00745	0.0109	CcSEcCtD
Zanamivir—Hallucination—Proguanil—malaria	0.00732	0.0108	CcSEcCtD
Zanamivir—Anaphylactoid reaction—Sulfadiazine—malaria	0.00729	0.0107	CcSEcCtD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—DECR1—malaria	0.00702	0.022	CbGpPWpGaD
Zanamivir—Anaphylactic shock—Pyrimethamine—malaria	0.00671	0.00986	CcSEcCtD
Zanamivir—Anorexia—Pyrimethamine—malaria	0.0064	0.00939	CcSEcCtD
Zanamivir—Toxic epidermal necrolysis—Sulfadiazine—malaria	0.00636	0.00934	CcSEcCtD
Zanamivir—Influenza like illness—Pentoxifylline—malaria	0.00622	0.00913	CcSEcCtD
Zanamivir—Nightmare—Quinidine barbiturate—malaria	0.00619	0.00909	CcSEcCtD
Zanamivir—Decreased appetite—Pyrimethamine—malaria	0.00583	0.00857	CcSEcCtD
Zanamivir—Cough—Proguanil—malaria	0.00559	0.00821	CcSEcCtD
Zanamivir—Ear pain—Pentoxifylline—malaria	0.00545	0.008	CcSEcCtD
Zanamivir—Anaphylactoid reaction—Clindamycin—malaria	0.00543	0.00798	CcSEcCtD
Zanamivir—Unspecified disorder of skin and subcutaneous tissue—Proguanil—malaria	0.00542	0.00795	CcSEcCtD
Zanamivir—Stevens-Johnson syndrome—Sulfadiazine—malaria	0.00539	0.00792	CcSEcCtD
Zanamivir—Skin disorder—Proguanil—malaria	0.00508	0.00746	CcSEcCtD
Zanamivir—Anorexia—Proguanil—malaria	0.00498	0.00732	CcSEcCtD
Zanamivir—Hypersensitivity—Pyrimethamine—malaria	0.00494	0.00726	CcSEcCtD
Zanamivir—Hallucination—Sulfadiazine—malaria	0.00486	0.00714	CcSEcCtD
Zanamivir—Anaphylactoid reaction—Pentoxifylline—malaria	0.0048	0.00705	CcSEcCtD
Zanamivir—Toxic epidermal necrolysis—Clindamycin—malaria	0.00473	0.00695	CcSEcCtD
Zanamivir—Influenza—Dapsone—malaria	0.0047	0.0069	CcSEcCtD
Zanamivir—Toxic epidermal necrolysis—Quinidine—malaria	0.00464	0.00682	CcSEcCtD
Zanamivir—Toxic epidermal necrolysis—Quinine—malaria	0.00464	0.00682	CcSEcCtD
Zanamivir—Erythema multiforme—Sulfadiazine—malaria	0.00462	0.00678	CcSEcCtD
Zanamivir—Decreased appetite—Proguanil—malaria	0.00454	0.00667	CcSEcCtD
Zanamivir—Asthma—Quinidine—malaria	0.00446	0.00655	CcSEcCtD
Zanamivir—Asthma—Quinine—malaria	0.00446	0.00655	CcSEcCtD
Zanamivir—Bronchospasm—Quinidine—malaria	0.00438	0.00644	CcSEcCtD
Zanamivir—Bronchospasm—Quinine—malaria	0.00438	0.00644	CcSEcCtD
Zanamivir—Chills—Sulfadiazine—malaria	0.00438	0.00644	CcSEcCtD
Zanamivir—Gastrointestinal pain—Proguanil—malaria	0.00427	0.00628	CcSEcCtD
Zanamivir—Vomiting—Pyrimethamine—malaria	0.00427	0.00627	CcSEcCtD
Zanamivir—Neutropenia—Clindamycin—malaria	0.00425	0.00624	CcSEcCtD
Zanamivir—Toxic epidermal necrolysis—Quinidine barbiturate—malaria	0.00419	0.00616	CcSEcCtD
Zanamivir—Neutropenia—Quinidine—malaria	0.00417	0.00612	CcSEcCtD
Zanamivir—Neutropenia—Quinine—malaria	0.00417	0.00612	CcSEcCtD
Zanamivir—Abdominal pain—Proguanil—malaria	0.00413	0.00607	CcSEcCtD
Zanamivir—Body temperature increased—Proguanil—malaria	0.00413	0.00607	CcSEcCtD
Zanamivir—Asthma—Quinidine barbiturate—malaria	0.00402	0.00591	CcSEcCtD
Zanamivir—Stevens-Johnson syndrome—Clindamycin—malaria	0.00402	0.0059	CcSEcCtD
Zanamivir—Bronchospasm—Quinidine barbiturate—malaria	0.00396	0.00581	CcSEcCtD
Zanamivir—Bronchospasm—Pentoxifylline—malaria	0.00395	0.0058	CcSEcCtD
Zanamivir—Stevens-Johnson syndrome—Quinidine—malaria	0.00394	0.00579	CcSEcCtD
Zanamivir—Stevens-Johnson syndrome—Quinine—malaria	0.00394	0.00579	CcSEcCtD
Zanamivir—Sinusitis—Dapsone—malaria	0.00393	0.00577	CcSEcCtD
Zanamivir—NEU2—Metabolism—DHODH—malaria	0.00391	0.0123	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—HPGDS—malaria	0.00385	0.0121	CbGpPWpGaD
Zanamivir—Neutropenia—Quinidine barbiturate—malaria	0.00376	0.00553	CcSEcCtD
Zanamivir—Convulsion—Sulfadiazine—malaria	0.00368	0.00541	CcSEcCtD
Zanamivir—Arthralgia—Sulfadiazine—malaria	0.00362	0.00532	CcSEcCtD
Zanamivir—Haemoglobin—Quinine—malaria	0.00359	0.00527	CcSEcCtD
Zanamivir—Haemoglobin—Quinidine—malaria	0.00359	0.00527	CcSEcCtD
Zanamivir—Diarrhoea—Proguanil—malaria	0.00358	0.00525	CcSEcCtD
Zanamivir—Haemorrhage—Quinidine—malaria	0.00357	0.00524	CcSEcCtD
Zanamivir—Haemorrhage—Quinine—malaria	0.00357	0.00524	CcSEcCtD
Zanamivir—Stevens-Johnson syndrome—Quinidine barbiturate—malaria	0.00356	0.00522	CcSEcCtD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—SCARB1—malaria	0.00353	0.0111	CbGpPWpGaD
Zanamivir—Anaphylactic shock—Sulfadiazine—malaria	0.00347	0.0051	CcSEcCtD
Zanamivir—Erythema multiforme—Clindamycin—malaria	0.00344	0.00505	CcSEcCtD
Zanamivir—Erythema multiforme—Quinine—malaria	0.00337	0.00495	CcSEcCtD
Zanamivir—Erythema multiforme—Quinidine—malaria	0.00337	0.00495	CcSEcCtD
Zanamivir—NEU2—Metabolism—SLC4A1—malaria	0.00333	0.0104	CbGpPWpGaD
Zanamivir—Vomiting—Proguanil—malaria	0.00332	0.00488	CcSEcCtD
Zanamivir—Anorexia—Sulfadiazine—malaria	0.00331	0.00486	CcSEcCtD
Zanamivir—Rash—Proguanil—malaria	0.0033	0.00484	CcSEcCtD
Zanamivir—Dermatitis—Proguanil—malaria	0.00329	0.00484	CcSEcCtD
Zanamivir—Headache—Proguanil—malaria	0.00327	0.00481	CcSEcCtD
Zanamivir—Haemoglobin—Quinidine barbiturate—malaria	0.00324	0.00475	CcSEcCtD
Zanamivir—Haemoglobin—Pentoxifylline—malaria	0.00323	0.00474	CcSEcCtD
Zanamivir—Haemorrhage—Quinidine barbiturate—malaria	0.00322	0.00473	CcSEcCtD
Zanamivir—Haemorrhage—Pentoxifylline—malaria	0.00321	0.00472	CcSEcCtD
Zanamivir—Hallucination—Quinidine barbiturate—malaria	0.0032	0.00471	CcSEcCtD
Zanamivir—Chills—Quinidine—malaria	0.0032	0.0047	CcSEcCtD
Zanamivir—Chills—Quinine—malaria	0.0032	0.0047	CcSEcCtD
Zanamivir—Musculoskeletal discomfort—Sulfadiazine—malaria	0.00316	0.00464	CcSEcCtD
Zanamivir—NEU2—Metabolism—DECR1—malaria	0.00313	0.0098	CbGpPWpGaD
Zanamivir—Nausea—Proguanil—malaria	0.0031	0.00456	CcSEcCtD
Zanamivir—Erythema multiforme—Quinidine barbiturate—malaria	0.00304	0.00447	CcSEcCtD
Zanamivir—Decreased appetite—Sulfadiazine—malaria	0.00302	0.00443	CcSEcCtD
Zanamivir—Chills—Quinidine barbiturate—malaria	0.00289	0.00424	CcSEcCtD
Zanamivir—Arrhythmia—Pentoxifylline—malaria	0.00287	0.00422	CcSEcCtD
Zanamivir—Cough—Dapsone—malaria	0.00286	0.0042	CcSEcCtD
Zanamivir—Agitation—Quinine—malaria	0.00285	0.00419	CcSEcCtD
Zanamivir—Agitation—Quinidine—malaria	0.00285	0.00419	CcSEcCtD
Zanamivir—Gastrointestinal pain—Sulfadiazine—malaria	0.00284	0.00417	CcSEcCtD
Zanamivir—NEU2—Metabolism—HBB—malaria	0.00283	0.00886	CbGpPWpGaD
Zanamivir—Syncope—Quinidine—malaria	0.00279	0.00409	CcSEcCtD
Zanamivir—Syncope—Quinine—malaria	0.00279	0.00409	CcSEcCtD
Zanamivir—Urticaria—Sulfadiazine—malaria	0.00276	0.00405	CcSEcCtD
Zanamivir—Abdominal pain—Sulfadiazine—malaria	0.00274	0.00403	CcSEcCtD
Zanamivir—Body temperature increased—Sulfadiazine—malaria	0.00274	0.00403	CcSEcCtD
Zanamivir—Loss of consciousness—Quinine—malaria	0.00273	0.00401	CcSEcCtD
Zanamivir—Loss of consciousness—Quinidine—malaria	0.00273	0.00401	CcSEcCtD
Zanamivir—Convulsion—Quinidine—malaria	0.00269	0.00395	CcSEcCtD
Zanamivir—Convulsion—Quinine—malaria	0.00269	0.00395	CcSEcCtD
Zanamivir—Discomfort—Clindamycin—malaria	0.00266	0.00391	CcSEcCtD
Zanamivir—Myalgia—Quinine—malaria	0.00264	0.00388	CcSEcCtD
Zanamivir—Myalgia—Quinidine—malaria	0.00264	0.00388	CcSEcCtD
Zanamivir—Unspecified disorder of skin and subcutaneous tissue—Quinidine—malaria	0.00263	0.00386	CcSEcCtD
Zanamivir—Unspecified disorder of skin and subcutaneous tissue—Quinine—malaria	0.00263	0.00386	CcSEcCtD
Zanamivir—Ill-defined disorder—Pentoxifylline—malaria	0.0026	0.00381	CcSEcCtD
Zanamivir—Anaphylactic shock—Clindamycin—malaria	0.00258	0.0038	CcSEcCtD
Zanamivir—Agitation—Quinidine barbiturate—malaria	0.00258	0.00378	CcSEcCtD
Zanamivir—Agitation—Pentoxifylline—malaria	0.00257	0.00378	CcSEcCtD
Zanamivir—Hypersensitivity—Sulfadiazine—malaria	0.00256	0.00375	CcSEcCtD
Zanamivir—Confusional state—Quinidine—malaria	0.00256	0.00375	CcSEcCtD
Zanamivir—Confusional state—Quinine—malaria	0.00256	0.00375	CcSEcCtD
Zanamivir—Malaise—Pentoxifylline—malaria	0.00252	0.00371	CcSEcCtD
Zanamivir—NEU2—Metabolism—PKLR—malaria	0.00252	0.0079	CbGpPWpGaD
Zanamivir—Syncope—Quinidine barbiturate—malaria	0.00251	0.00369	CcSEcCtD
Zanamivir—Shock—Quinidine—malaria	0.00249	0.00366	CcSEcCtD
Zanamivir—Shock—Quinine—malaria	0.00249	0.00366	CcSEcCtD
Zanamivir—Loss of consciousness—Quinidine barbiturate—malaria	0.00246	0.00362	CcSEcCtD
Zanamivir—Skin disorder—Quinine—malaria	0.00246	0.00362	CcSEcCtD
Zanamivir—Skin disorder—Quinidine—malaria	0.00246	0.00362	CcSEcCtD
Zanamivir—Convulsion—Quinidine barbiturate—malaria	0.00243	0.00357	CcSEcCtD
Zanamivir—Convulsion—Pentoxifylline—malaria	0.00242	0.00356	CcSEcCtD
Zanamivir—Anorexia—Quinidine—malaria	0.00242	0.00355	CcSEcCtD
Zanamivir—Anorexia—Quinine—malaria	0.00242	0.00355	CcSEcCtD
Zanamivir—Myalgia—Quinidine barbiturate—malaria	0.00239	0.00351	CcSEcCtD
Zanamivir—Arthralgia—Quinidine barbiturate—malaria	0.00239	0.00351	CcSEcCtD
Zanamivir—Myalgia—Pentoxifylline—malaria	0.00238	0.0035	CcSEcCtD
Zanamivir—Anxiety—Quinidine barbiturate—malaria	0.00238	0.00349	CcSEcCtD
Zanamivir—Diarrhoea—Sulfadiazine—malaria	0.00237	0.00349	CcSEcCtD
Zanamivir—Anxiety—Pentoxifylline—malaria	0.00237	0.00349	CcSEcCtD
Zanamivir—Unspecified disorder of skin and subcutaneous tissue—Quinidine barbiturate—malaria	0.00237	0.00348	CcSEcCtD
Zanamivir—Unspecified disorder of skin and subcutaneous tissue—Pentoxifylline—malaria	0.00237	0.00347	CcSEcCtD
Zanamivir—Discomfort—Pentoxifylline—malaria	0.00235	0.00346	CcSEcCtD
Zanamivir—Musculoskeletal discomfort—Quinidine—malaria	0.00231	0.00339	CcSEcCtD
Zanamivir—Musculoskeletal discomfort—Quinine—malaria	0.00231	0.00339	CcSEcCtD
Zanamivir—Confusional state—Quinidine barbiturate—malaria	0.00231	0.00339	CcSEcCtD
Zanamivir—Dyspnoea—Clindamycin—malaria	0.0023	0.00338	CcSEcCtD
Zanamivir—Confusional state—Pentoxifylline—malaria	0.0023	0.00338	CcSEcCtD
Zanamivir—Anaphylactic shock—Pentoxifylline—malaria	0.00228	0.00335	CcSEcCtD
Zanamivir—Infection—Pentoxifylline—malaria	0.00227	0.00333	CcSEcCtD
Zanamivir—Dyspnoea—Quinine—malaria	0.00226	0.00332	CcSEcCtD
Zanamivir—Dyspnoea—Quinidine—malaria	0.00226	0.00332	CcSEcCtD
Zanamivir—Shock—Quinidine barbiturate—malaria	0.00225	0.00331	CcSEcCtD
Zanamivir—NEU2—Metabolism—G6PD—malaria	0.00225	0.00704	CbGpPWpGaD
Zanamivir—Shock—Pentoxifylline—malaria	0.00225	0.0033	CcSEcCtD
Zanamivir—Fatigue—Clindamycin—malaria	0.00223	0.00327	CcSEcCtD
Zanamivir—Skin disorder—Quinidine barbiturate—malaria	0.00222	0.00326	CcSEcCtD
Zanamivir—Skin disorder—Pentoxifylline—malaria	0.00222	0.00326	CcSEcCtD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—CD36—malaria	0.00222	0.00695	CbGpPWpGaD
Zanamivir—Pain—Clindamycin—malaria	0.00221	0.00325	CcSEcCtD
Zanamivir—Vomiting—Sulfadiazine—malaria	0.00221	0.00324	CcSEcCtD
Zanamivir—Decreased appetite—Quinidine—malaria	0.0022	0.00324	CcSEcCtD
Zanamivir—Decreased appetite—Quinine—malaria	0.0022	0.00324	CcSEcCtD
Zanamivir—Rash—Sulfadiazine—malaria	0.00219	0.00321	CcSEcCtD
Zanamivir—Dermatitis—Sulfadiazine—malaria	0.00219	0.00321	CcSEcCtD
Zanamivir—Gastrointestinal pain—Dapsone—malaria	0.00218	0.00321	CcSEcCtD
Zanamivir—Anorexia—Quinidine barbiturate—malaria	0.00218	0.0032	CcSEcCtD
Zanamivir—Anorexia—Pentoxifylline—malaria	0.00218	0.0032	CcSEcCtD
Zanamivir—Headache—Sulfadiazine—malaria	0.00217	0.00319	CcSEcCtD
Zanamivir—Gastrointestinal pain—Clindamycin—malaria	0.00211	0.0031	CcSEcCtD
Zanamivir—Abdominal pain—Dapsone—malaria	0.00211	0.0031	CcSEcCtD
Zanamivir—Body temperature increased—Dapsone—malaria	0.00211	0.0031	CcSEcCtD
Zanamivir—Feeling abnormal—Quinidine—malaria	0.00209	0.00307	CcSEcCtD
Zanamivir—Feeling abnormal—Quinine—malaria	0.00209	0.00307	CcSEcCtD
Zanamivir—Musculoskeletal discomfort—Quinidine barbiturate—malaria	0.00208	0.00306	CcSEcCtD
Zanamivir—Musculoskeletal discomfort—Pentoxifylline—malaria	0.00208	0.00306	CcSEcCtD
Zanamivir—Gastrointestinal pain—Quinidine—malaria	0.00207	0.00304	CcSEcCtD
Zanamivir—Gastrointestinal pain—Quinine—malaria	0.00207	0.00304	CcSEcCtD
Zanamivir—Nausea—Sulfadiazine—malaria	0.00206	0.00303	CcSEcCtD
Zanamivir—Urticaria—Clindamycin—malaria	0.00205	0.00302	CcSEcCtD
Zanamivir—Abdominal pain—Clindamycin—malaria	0.00204	0.003	CcSEcCtD
Zanamivir—Body temperature increased—Clindamycin—malaria	0.00204	0.003	CcSEcCtD
Zanamivir—Dyspnoea—Quinidine barbiturate—malaria	0.00204	0.003	CcSEcCtD
Zanamivir—Dyspnoea—Pentoxifylline—malaria	0.00204	0.00299	CcSEcCtD
Zanamivir—Urticaria—Quinidine—malaria	0.00201	0.00296	CcSEcCtD
Zanamivir—Urticaria—Quinine—malaria	0.00201	0.00296	CcSEcCtD
Zanamivir—Abdominal pain—Quinidine—malaria	0.002	0.00294	CcSEcCtD
Zanamivir—Abdominal pain—Quinine—malaria	0.002	0.00294	CcSEcCtD
Zanamivir—Body temperature increased—Quinidine—malaria	0.002	0.00294	CcSEcCtD
Zanamivir—Body temperature increased—Quinine—malaria	0.002	0.00294	CcSEcCtD
Zanamivir—Decreased appetite—Quinidine barbiturate—malaria	0.00199	0.00292	CcSEcCtD
Zanamivir—Decreased appetite—Pentoxifylline—malaria	0.00199	0.00292	CcSEcCtD
Zanamivir—Pain—Quinidine barbiturate—malaria	0.00196	0.00287	CcSEcCtD
Zanamivir—Hypersensitivity—Clindamycin—malaria	0.0019	0.0028	CcSEcCtD
Zanamivir—Feeling abnormal—Quinidine barbiturate—malaria	0.00189	0.00277	CcSEcCtD
Zanamivir—Feeling abnormal—Pentoxifylline—malaria	0.00188	0.00276	CcSEcCtD
Zanamivir—Gastrointestinal pain—Quinidine barbiturate—malaria	0.00187	0.00275	CcSEcCtD
Zanamivir—Hypersensitivity—Quinidine—malaria	0.00187	0.00274	CcSEcCtD
Zanamivir—Hypersensitivity—Quinine—malaria	0.00187	0.00274	CcSEcCtD
Zanamivir—Gastrointestinal pain—Pentoxifylline—malaria	0.00187	0.00274	CcSEcCtD
Zanamivir—Asthenia—Clindamycin—malaria	0.00185	0.00272	CcSEcCtD
Zanamivir—Asthenia—Quinine—malaria	0.00182	0.00267	CcSEcCtD
Zanamivir—Asthenia—Quinidine—malaria	0.00182	0.00267	CcSEcCtD
Zanamivir—Urticaria—Quinidine barbiturate—malaria	0.00182	0.00267	CcSEcCtD
Zanamivir—Urticaria—Pentoxifylline—malaria	0.00181	0.00266	CcSEcCtD
Zanamivir—Abdominal pain—Quinidine barbiturate—malaria	0.00181	0.00266	CcSEcCtD
Zanamivir—Body temperature increased—Quinidine barbiturate—malaria	0.00181	0.00266	CcSEcCtD
Zanamivir—Body temperature increased—Pentoxifylline—malaria	0.00181	0.00265	CcSEcCtD
Zanamivir—Abdominal pain—Pentoxifylline—malaria	0.00181	0.00265	CcSEcCtD
Zanamivir—Diarrhoea—Clindamycin—malaria	0.00177	0.0026	CcSEcCtD
Zanamivir—Diarrhoea—Quinidine—malaria	0.00173	0.00255	CcSEcCtD
Zanamivir—Diarrhoea—Quinine—malaria	0.00173	0.00255	CcSEcCtD
Zanamivir—NEU2—Metabolism—HPGDS—malaria	0.00171	0.00537	CbGpPWpGaD
Zanamivir—Dizziness—Clindamycin—malaria	0.00171	0.00251	CcSEcCtD
Zanamivir—Vomiting—Dapsone—malaria	0.0017	0.00249	CcSEcCtD
Zanamivir—Hypersensitivity—Quinidine barbiturate—malaria	0.00169	0.00248	CcSEcCtD
Zanamivir—Hypersensitivity—Pentoxifylline—malaria	0.00168	0.00247	CcSEcCtD
Zanamivir—Dizziness—Quinine—malaria	0.00168	0.00246	CcSEcCtD
Zanamivir—Dizziness—Quinidine—malaria	0.00168	0.00246	CcSEcCtD
Zanamivir—Headache—Dapsone—malaria	0.00167	0.00246	CcSEcCtD
Zanamivir—Vomiting—Clindamycin—malaria	0.00164	0.00241	CcSEcCtD
Zanamivir—Asthenia—Quinidine barbiturate—malaria	0.00164	0.00241	CcSEcCtD
Zanamivir—Asthenia—Pentoxifylline—malaria	0.00164	0.00241	CcSEcCtD
Zanamivir—Rash—Clindamycin—malaria	0.00163	0.00239	CcSEcCtD
Zanamivir—Dermatitis—Clindamycin—malaria	0.00163	0.00239	CcSEcCtD
Zanamivir—Headache—Clindamycin—malaria	0.00162	0.00238	CcSEcCtD
Zanamivir—Vomiting—Quinidine—malaria	0.00161	0.00237	CcSEcCtD
Zanamivir—Vomiting—Quinine—malaria	0.00161	0.00237	CcSEcCtD
Zanamivir—Rash—Quinine—malaria	0.0016	0.00235	CcSEcCtD
Zanamivir—Rash—Quinidine—malaria	0.0016	0.00235	CcSEcCtD
Zanamivir—Dermatitis—Quinidine—malaria	0.0016	0.00235	CcSEcCtD
Zanamivir—Dermatitis—Quinine—malaria	0.0016	0.00235	CcSEcCtD
Zanamivir—NEU2—Metabolism—DHFR—malaria	0.00159	0.00498	CbGpPWpGaD
Zanamivir—Headache—Quinine—malaria	0.00159	0.00233	CcSEcCtD
Zanamivir—Headache—Quinidine—malaria	0.00159	0.00233	CcSEcCtD
Zanamivir—Nausea—Dapsone—malaria	0.00159	0.00233	CcSEcCtD
Zanamivir—NEU2—Metabolism—SCARB1—malaria	0.00157	0.00493	CbGpPWpGaD
Zanamivir—Diarrhoea—Quinidine barbiturate—malaria	0.00157	0.0023	CcSEcCtD
Zanamivir—Diarrhoea—Pentoxifylline—malaria	0.00156	0.00229	CcSEcCtD
Zanamivir—Nausea—Clindamycin—malaria	0.00153	0.00225	CcSEcCtD
Zanamivir—Dizziness—Quinidine barbiturate—malaria	0.00151	0.00222	CcSEcCtD
Zanamivir—Dizziness—Pentoxifylline—malaria	0.00151	0.00222	CcSEcCtD
Zanamivir—Nausea—Quinine—malaria	0.00151	0.00221	CcSEcCtD
Zanamivir—Nausea—Quinidine—malaria	0.00151	0.00221	CcSEcCtD
Zanamivir—Vomiting—Quinidine barbiturate—malaria	0.00145	0.00214	CcSEcCtD
Zanamivir—Vomiting—Pentoxifylline—malaria	0.00145	0.00213	CcSEcCtD
Zanamivir—Rash—Quinidine barbiturate—malaria	0.00144	0.00212	CcSEcCtD
Zanamivir—Dermatitis—Quinidine barbiturate—malaria	0.00144	0.00212	CcSEcCtD
Zanamivir—Rash—Pentoxifylline—malaria	0.00144	0.00211	CcSEcCtD
Zanamivir—Dermatitis—Pentoxifylline—malaria	0.00144	0.00211	CcSEcCtD
Zanamivir—Headache—Quinidine barbiturate—malaria	0.00143	0.00211	CcSEcCtD
Zanamivir—Headache—Pentoxifylline—malaria	0.00143	0.0021	CcSEcCtD
Zanamivir—Nausea—Quinidine barbiturate—malaria	0.00136	0.002	CcSEcCtD
Zanamivir—Nausea—Pentoxifylline—malaria	0.00136	0.00199	CcSEcCtD
Zanamivir—NEU2—Metabolism—CD36—malaria	0.000988	0.00309	CbGpPWpGaD
